IL23R gene – Talk Bio

Actionable Insights Powered by AI

AbbVie Expands Immunology Pipeline with $200M Acquisition of Nimble Therapeutics

AbbVie, Nimble Therapeutics, Immunology, Psoriasis, Autoimmune Diseases, IL23R Inhibitor, Peptide Therapeutics